Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
6.65
Dollar change
+0.17
Percentage change
2.62
%
Index- P/E70.37 EPS (ttm)0.09 Insider Own0.06% Shs Outstand256.91M Perf Week5.72%
Market Cap1.71B Forward P/E5.45 EPS next Y1.22 Insider Trans0.00% Shs Float256.76M Perf Month-28.49%
Income64.22M PEG2.17 EPS next Q- Inst Own48.54% Short Float3.19% Perf Quarter-35.62%
Sales7.13B P/S0.24 EPS this Y149.22% Inst Trans-0.02% Short Ratio2.44 Perf Half Y-27.40%
Book/sh25.06 P/B0.27 EPS next Y36.61% ROA0.27% Short Interest8.19M Perf Year-5.67%
Cash/sh2.28 P/C2.92 EPS next 5Y32.40% ROE0.99% 52W Range5.30 - 12.15 Perf YTD-42.47%
Dividend Est.0.02 (0.28%) P/FCF- EPS past 5Y-37.97% ROI0.39% 52W High-45.27% Beta0.55
Dividend TTM- Quick Ratio1.29 Sales past 5Y6.28% Gross Margin35.24% 52W Low25.47% ATR (14)0.50
Dividend Ex-DateJun 03, 2021 Current Ratio2.79 EPS Y/Y TTM-71.15% Oper. Margin11.12% RSI (14)47.08 Volatility6.06% 7.98%
Employees23744 Debt/Eq1.74 Sales Y/Y TTM11.94% Profit Margin0.90% Recom2.20 Target Price15.20
Option/ShortYes / Yes LT Debt/Eq1.58 EPS Q/Q-63.47% Payout0.00% Rel Volume0.28 Prev Close6.48
Sales Surprise1.83% EPS Surprise-27.22% Sales Q/Q26.87% Earnings- Avg Volume3.35M Price6.65
SMA202.06% SMA50-11.11% SMA200-26.12% Trades Volume950,032 Change2.62%
Date Action Analyst Rating Change Price Target Change
Mar-12-24Downgrade Deutsche Bank Hold → Sell
Apr-12-23Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-03-23Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-16-23Upgrade Barclays Underweight → Equal Weight
Jan-18-23Upgrade Jefferies Hold → Buy
Apr-08-22Initiated Morgan Stanley Equal-Weight
Nov-05-21Downgrade Deutsche Bank Buy → Hold
Oct-19-21Downgrade Barclays Overweight → Underweight
Oct-06-21Upgrade Citigroup Neutral → Buy
Jun-14-21Upgrade Deutsche Bank Hold → Buy
Mar-25-24 01:25PM
Mar-22-24 08:03AM
Mar-20-24 01:21PM
Mar-08-24 06:25PM
12:34PM
05:06AM Loading…
05:06AM
Mar-06-24 06:29PM
03:21PM
Feb-29-24 03:51PM
02:04PM
Feb-21-24 11:32AM
Feb-14-24 03:16AM
Feb-12-24 11:56AM
07:03AM
07:03AM
01:02PM Loading…
Feb-08-24 01:02PM
Feb-05-24 09:55AM
Feb-01-24 08:05PM
10:15AM
Jan-26-24 02:49PM
02:01PM
01:03PM
Jan-25-24 12:24PM
Jan-23-24 05:05PM
Jan-19-24 12:32PM
Jan-18-24 08:36AM
Jan-17-24 05:44AM
Jan-16-24 05:39PM
Jan-15-24 09:35AM
Jan-14-24 03:16PM
03:06PM Loading…
03:06PM
Jan-12-24 12:16PM
11:37AM
05:22AM
Jan-11-24 11:49AM
08:57AM
06:17AM
Jan-10-24 10:59AM
07:01AM
05:24AM
Jan-09-24 07:44PM
02:19PM
01:18PM
01:07PM
12:22PM
11:53AM
11:24AM
11:07AM
09:47AM
08:55AM
08:52AM
05:00AM
02:22AM
Jan-08-24 11:50AM
Dec-29-23 09:41AM
Dec-14-23 06:30PM
12:00PM
Dec-12-23 08:00AM
Nov-16-23 05:00AM
Nov-15-23 08:00AM
Nov-06-23 08:00AM
Nov-03-23 04:07PM
02:56PM
Oct-24-23 06:30PM
Oct-19-23 08:00AM
Sep-28-23 08:00AM
Sep-14-23 11:40AM
Sep-12-23 12:00PM
09:40AM
Aug-22-23 06:25PM
Aug-01-23 08:00AM
Jul-31-23 06:50PM
Jul-28-23 07:44PM
Jul-21-23 09:40AM
Jul-20-23 08:15AM
Jul-18-23 08:00AM
Jul-13-23 08:00AM
Jun-14-23 04:56AM
May-11-23 08:30AM
May-09-23 05:17PM
03:39PM
Apr-18-23 10:30AM
Mar-31-23 10:15PM
Mar-27-23 11:15AM
Mar-26-23 08:45AM
Mar-15-23 09:40AM
Mar-07-23 06:31PM
12:00PM
Mar-06-23 07:00AM
Feb-28-23 07:16PM
03:23AM
Feb-27-23 09:40AM
Feb-17-23 05:07PM
Feb-15-23 12:22PM
Feb-10-23 09:40AM
Jan-04-23 06:41PM
Dec-14-22 04:00AM
Nov-03-22 09:00AM
Oct-24-22 10:13AM
Oct-21-22 08:09AM
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jose Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.